AMANDA BAKER: Open Payments
NPI 1326708421 · DEER PARK, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$362 in 18 payments from 9 companies in 2025. Trend: 2023 $476 · 2024 $688 · 2025 $362
Food & beverage: $362
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 8 | $137 |
| Phathom Pharmaceuticals, Inc. | 2 | $50 |
| ABBVIE INC. | 2 | $47 |
| Neurocrine BioSciences, Inc. | 1 | $26 |
| Corcept Therapeutics | 1 | $25 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $22 |
| Novartis Pharmaceuticals Corporation | 1 | $21 |
| Edwards Lifesciences Corporation | 1 | $17 |
| Novo Nordisk Inc | 1 | $17 |
Products named: FARXIGA, VOQUEZNA, CREON, INGREZZA, Korlym, JARDIANCE, ENTRESTO, VRAYLAR.
Industry payments across WA — which companies pay providers there.
